Dialysis Disequilibrium Syndrome

Dialysis Disequilibrium Syndrome (DDS) 

Dialysis Disequilibrium Syndrome (DDS) is an acute neurological syndrome that occurs during or shortly after hemodialysis, caused by rapid reduction in plasma osmolality, leading to movement of water into brain cells, resulting in cerebral edema and raised intracranial pressure (ICP).

it is a diagnosis of exclusion.

Pathophysiology

Mechanism

Pathophysiology / Effect Leading to Dialysis Disequilibrium Syndrome (DDS)

Reverse urea effect (major mechanism)

During rapid hemodialysis, plasma urea decreases faster than brain urea because urea exits the brain more slowly. This creates an osmotic gradient, causing water to move into brain cells, resulting in cerebral edema.

Brain intracellular osmoles (idiogenic osmoles)

In chronic uremia, the brain retains myo-inositol, glutamine, and taurine, which increase intracellular osmolality. During dialysis, these osmoles are removed slowly, promoting water influx into brain cells and cerebral edema.

Intracellular acidosis

Hemodialysis rapidly corrects systemic metabolic acidosis, but brain intracellular pH normalizes more slowly, causing persistent intracellular acidosis. This increases intracellular osmolality, leading to water entry into brain cells and cerebral edema.

Aquaporin-4 upregulation

Experimental studies demonstrate upregulation of aquaporin-4 (AQP4) channels in astrocytes during uremia, facilitating greater water influx into astrocytes and worsening brain edema.

Increased blood–brain barrier (BBB) permeability

Severe uremia induces systemic inflammation, leading to BBB dysfunction. Increased BBB permeability allows greater water movement into the brain, contributing to cerebral edema during dialysis.

Osmotic changes during dialysis

Before dialysis: Blood osmolality ≈ 320 mOsm/kg, Brain osmolality ≈ 320 mOsm/kg(equilibrium).

After rapid dialysis: Blood osmolality falls to ≈ 290 mOsm/kg, while Brain osmolality remains relatively high (≈ 315 mOsm/kg). The resulting osmotic gradient drives water into the brain, causing brain swelling (cerebral edema) and the clinical manifestations of DDS.

Step 1: Severe uremia

Patient has

  • Very high BUN
  • High plasma osmolality

Example

BUN = 180 mg/dL

Blood osmolality is elevated.

Brain adapts over several days.


Step 2: Brain adaptation

Because uremia develops slowly:

Brain cells compensate by increasing intracellular osmoles called:

Idiogenic osmoles

Purpose:Prevent brain dehydration.Thus,Brain osmolality becomes similar to plasma.


Step 3: Rapid dialysis

Hemodialysis removes urea rapidly from blood.

Example

Blood:BUN 180 70 mg/dL within 3 hours

But brain urea decreases much more slowly because:

  • Blood-brain barrier limits diffusion
  • Urea transporter equilibration takes time

Now:Blood osmolality becomes lower than brain osmolality.


Risk Factors

Risk Factor

Mechanism 

First hemodialysis session

Most common setting for DDS. Patients have the highest urea burden, and rapid urea removal creates a large osmotic gradient between plasma and the brain, promoting cerebral edema.

Chronic dialysis patients who miss their regular dialysis treatments.

High BUN (>100–150 mg/dL)

Risk increases markedly as blood urea nitrogen (BUN) exceeds 100–150 mg/dL. Older literature often cited 175–200 mg/dL as very high risk. Modern practice aims to initiate dialysis before BUN reaches these levels.

Pediatric patients

Children have a larger brain-to-skull volume ratio with less intracranial reserve, making them more susceptible to cerebral edema from osmotic shifts.

Elderly patients

Reduced cerebral compliance and impaired physiological reserve increase susceptibility to neurological complications during rapid osmotic changes.

Hypernatremia

Rapid correction of elevated serum sodium produces large osmotic shifts, increasing the risk of water movement into the brain and cerebral edema.

Hyperglycemia

Marked changes in serum glucose alter plasma osmolality. Rapid correction may produce significant osmotic gradients, increasing the risk of DDS.

Severe metabolic acidosis

Rapid correction of acidosis during dialysis can contribute to intracellular brain acidosis and osmotic water movement into brain cells, increasing the risk of cerebral edema.

Pre-existing neurologic disease

Conditions such as stroke, traumatic brain injury, brain tumor, CNS infection, and intracranial hemorrhage reduce the brain’s ability to tolerate cerebral edema, increasing DDS risk.

Chronic kidney disease with prolonged untreated uremia

Long-standing uremia allows the brain to accumulate idiogenic osmoles and adapt to a hyperosmolar state. Rapid dialysis disrupts this adaptation, predisposing to cerebral edema.

Very rapid or high-efficiency dialysis

Use of large dialyzers, high blood flow rates, high dialysate flow rates, and aggressive urea clearance produces rapid reductions in plasma osmolality, creating large osmotic gradients that favor water movement into the brain and development of DDS.

Clinical Presentation

Symptoms begin During dialysis or Within several hours afterward.

Severity

Clinical Features 

Mild(Mostly)

Headache, restlessness, nausea, vomiting, muscle cramps, blurred vision, fatigue, and dizziness. These symptoms usually occur during or shortly after dialysis and often represent early cerebral edema.

Moderate

Confusion, disorientation, agitation, myoclonus, tremor, hypertension, and somnolence, indicating progressive cerebral dysfunction due to worsening cerebral edema.

Severe

Seizures, coma, brain herniation, respiratory arrest, and death. These are life-threatening manifestations of severe cerebral edema and require immediate intervention.

Time Course

Usually 30 minutes to 6 hours after dialysis,Peak-Immediately after dialysis


Physical Examination May reveal

  • Papilledema (rare)
  • Hypertension
  • Bradycardia (late ICP)
  • Abnormal pupils
  • Altered sensorium
  • Hyperreflexia
  • Seizures

Differential Diagnosis

Condition

Distinguishing Features

PRES

If too much B.P fluctuations

Uremic encephalopathy

Improves with dialysis rather than worsens

Hypoglycemia

Low glucose

Hyponatremia

Low Na

Stroke

Focal deficits

Intracranial bleed

CT positive

Air embolism

Sudden collapse during HD

Dialyzer reaction

Hypotension, wheezing

Electrolyte disorders

Lab abnormalities

Drug toxicity

Medication history

Diagnosis

DDS is primarily a clinical diagnosis.

Based on:

  • Recent dialysis
  • High-risk patient
  • Compatible neurological symptoms
  • Exclusion of other causes

No laboratory test confirms DDS.


Investigations

Investigation

Purpose / Typical Findings in Dialysis Disequilibrium Syndrome (DDS)

Blood tests

Assess for metabolic abnormalities that may mimic or worsen DDS. Important tests include serum electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻), blood glucose, serum calcium, arterial blood gas (ABG), blood urea nitrogen (BUN), and serum creatinine.

CT brain (non-contrast)

Usually normal in the early stages of DDS. Primarily performed to exclude alternative neurological emergencies, such as intracranial hemorrhage, acute ischemic stroke, or hydrocephalus. Severe cerebral edema may occasionally be evident in advanced cases.

MRI brain

More sensitive than CT for detecting cerebral edema. May demonstrate diffuse cerebral edema, cortical or white matter swelling, and occasionally areas of restricted diffusion. MRI is not routinely required immediately and is generally reserved for atypical presentations or persistent neurological deficits after stabilization.

Prevention 

Principle-Prevent rapid fall in plasma osmolality.


1. Slow dialysis

  • Most effective strategy.
  • First dialysis 2 hours rather than 4 hours.


2. Small dialyzer

Lower clearance.


3. Lower blood flow

Typical first HD—Blood flow-150–200 mL/min instead of 300–400 mL/min


4. Lower dialysate flow

Reduce urea removal.


5. Short dialysis sessions

Example 2 hours Daily instead of 4-hour alternate-day HD


6. Target modest urea reduction

During the initial dialysis session:

  • Aim for a urea reduction ratio (URR) of approximately 30–40%, rather than the usual 65–70% used for maintenance dialysis.
  • Increase dialysis intensity gradually over subsequent sessions as the patient adapts.

7. High sodium dialysate

Higher dialysate sodium Maintains plasma osmolality and Reduces water shift


8. Replace the urea with another osmotically active substance during the dialysis procedure, thus maintaining plasma osmolality.

Mannitol prophylaxis

  • Common ICU practice
  • 0.5–1 g/kg IV during dialysis
  • Maintains plasma osmolality.
  • Evidence is limited but supportive in selected high-risk patients.

Hypertonic saline

  • Occasionally used
  • High-risk patients
  • especially with severe symptoms.

10. Use CRRT instead of intermittent HD

Best option for:

  • Severe uremia
  • Brain injury
  • Raised ICP
  • Acute liver failure
  • Neurosurgical ICU
  • Hemodynamic instability

CRRT removes urea gradually.


Treatment

Initial Management of Dialysis Disequilibrium Syndrome (DDS)

Step 1. Recognize DDS Early

Step 2. Modify the Dialysis Prescription (Preferred Initial Intervention)

For mild to moderate DDS, dialysis usually does not need to be stopped immediately.

Instead, reduce the rate of osmotic change by modifying the dialysis prescription (“sodium remodeling” or “sodium profiling”).

A. Sodium remodeling (preferred)

Increase the dialysate sodium concentration above the patient’s serum sodium (commonly 145–150 mmol/L, individualized to the clinical situation).

Symptoms often improve within 15–30 minutes.


B. Reduce dialysis efficiency

Reduce:

  • Blood flow rate (Qb)
  • Dialysate flow rate (Qd)
  • Urea clearance
  • Ultrafiltration rate (if contributing)

This slows the fall in plasma osmolality.


C. Shorten the dialysis session

If symptoms persist despite sodium remodeling, shorten the treatment and complete the remaining dialysis later.


Step 3. Reassess After 15–30 Minutes

If symptoms improve:

  • Continue dialysis with the modified prescription.
  • Plan subsequent dialysis sessions with lower efficiency and gradual escalation.

If symptoms worsen or fail to improve:

  • Stop dialysis.
  • Evaluate for alternative neurological emergencies.

Step 4. Symptomatic Treatment

For persistent but mild symptoms:

  • Antiemetics for nausea/vomiting
  • Analgesics for headache (avoid excessive sedation)
  • Close neurological monitoring

Step 5. Management of Severe DDS

Immediately discontinue dialysis if any of the following occur:

  • Seizures
  • Coma
  • Rapid neurological deterioration
  • Signs of raised intracranial pressure
  • Suspected cerebral herniation

Then:

  • Secure airway and breathing.
  • Treat seizures (IV lorazepam or diazepam, followed by an antiseizure medication if needed).
  • Administer osmotherapy:
    • Mannitol 0.5–1 g/kg IV, or
    • 3% hypertonic saline when appropriate (especially if hyponatremia is present or mannitol is contraindicated).
  • Obtain urgent neuroimaging to exclude intracranial hemorrhage or ischemic stroke.
  • Resume renal replacement later using low-efficiency hemodialysis or preferably CRRT in high-risk patients.

Complications

  • Cerebral edema
  • Raised intracranial pressure
  • Status epilepticus
  • Brain herniation
  • Respiratory arrest
  • Permanent neurological deficits (rare)
  • Death (very rare with current preventive strategies)

Prognosis

  • Mild DDS generally resolves completely within hours to 1–2 days with supportive care.
  • Severe DDS may require ICU care and osmotherapy.
  • Permanent neurological injury is uncommon if recognized and treated promptly.
  • Prevention is far more effective than treatment.

DDS vs Uremic Encephalopathy

Feature

Dialysis Disequilibrium Syndrome

Uremic Encephalopathy

Cause

Rapid dialysis-induced osmotic shift

Accumulation of uremic toxins

Timing

During or soon after dialysis

Before dialysis

BUN

Falls rapidly

Persistently elevated

Brain edema

Present

Usually absent

Effect of dialysis

Symptoms worsen

Symptoms improve

Treatment

Slow/stop dialysis, osmotherapy

Dialysis

Guideline and Reference Sources

  1. Mistry K. Dialysis disequilibrium syndrome prevention and management. Int J Nephrol Renovasc Dis. 2019 Apr 30;12:69-77. doi: 10.2147/IJNRD.S165925. PMID: 31118737; PMCID: PMC6503314.
  2. Bhandari B, Komanduri S. Dialysis Disequilibrium Syndrome. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559018/